(Q43461206)

English

Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

scientific article published on 21 August 2012

Statements

Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma (English)
Alexander B Stillebroer
Ingrid M E Desar
Marije J Boers-Sonderen
Carla M L van Herpen
Johannes F Langenhuijsen
Peter M Smith-Jones
Egbert Oosterwijk
Peter F A Mulders

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit